MARKET

IMNN

IMNN

Imunon Inc
NASDAQ
2.020
+0.010
+0.50%
Pre Market: 2.180 +0.16 +7.92% 08:02 07/13 EDT
OPEN
2.040
PREV CLOSE
2.010
HIGH
2.109
LOW
1.940
VOLUME
2
TURNOVER
0
52 WEEK HIGH
11.96
52 WEEK LOW
1.700
MARKET CAP
8.49M
P/E (TTM)
-0.3517
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IMNN last week (0706-0710)?
Weekly Report · 2h ago
Imunon files Form 3 for CFO Joshua Blacher
PUBT · 5d ago
Imunon General Counsel Susan Eylward disposes of 920 common shares worth $1,729.6
PUBT · 5d ago
Weekly Report: what happened at IMNN last week (0629-0703)?
Weekly Report · 07/06 10:05
IMUNON announces executive transition: Josh Blacher appointed interim CFO as Jeffrey Church retires
Seeking Alpha · 07/01 04:38
Imunon interim CFO Jeffrey Church to retire, Josh Blacher to succeed
TipRanks · 06/30 22:25
*Imunon CFO Jeffrey Church Retires
Dow Jones · 06/30 22:15
Imunon Names Josh Blacher Interim Chief Financial Officer
TipRanks · 06/30 21:05
More
About IMNN
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases, constituting a differentiating approach from conventional therapies. The Company is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors. The second modality, PlaCCine, is developed for the gene delivery of viral antigens that can elicit a strong immunological response. The Company’s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer that has completed Phase 2 development. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site.

Webull offers Imunon Inc stock information, including NASDAQ: IMNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMNN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMNN stock methods without spending real money on the virtual paper trading platform.